Fibrotic Bronchial Epithelial Cell Jamming Transition Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective models for understanding and addressing the pathological distal airway phenotype in pulmonary fibrosis, particularly in idiopathic pulmonary fibrosis (IPF), where airway epithelium remodeling and fibrosis progression are critical but poorly understood.
Innovation Solution
The development of methods to screen test compounds and identify biomarkers for inducing an unjammed-to-jammed transition (UJT) in fibrotic primary human bronchial epithelial cells, using culturing techniques at an air-liquid interface and monitoring cell motility, along with specific cytokine and inhibitor treatments to modulate the ERBB-YAP axis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If fibrotic primary human bronchial epithelial cells are cultured at air-liquid interface to differentiate into pseudostratified epithelium, then the model better recapitulates in vivo airway phenotype, but the culture time and complexity increase
Solution Approach 1:
The air-liquid interface culture system divides the culture environment into distinct apical (air-exposed) and basal (media-exposed) zones, allowing independent optimization of differentiation conditions at the airway surface while maintaining barrier function through the epithelial layer
Solution Approach 2:
The culture system creates an in vitro replica of the in vivo airway epithelium by establishing pseudostratified architecture with ciliated, goblet, and basal cells, enabling study of IPF pathogenesis without requiring complex animal models or human tissue samples
2Productivity
If cell motility is monitored to identify unjammed-to-jammed transition, then therapeutic screening capability is improved, but measurement precision requirements increase
Solution Approach 1:
The method utilizes changes in cellular visual morphology and arrangement patterns (analogous to color changes) to detect the jamming transition, where cells shift from a disorganized motile state to an organized stationary state, enabling screening through microscopy without requiring complex quantitative measurements
3Reliability
If IL-6 family cytokines or SRC/YAP activators are administered to induce jammed phase, then fibrosis progression can be halted, but cell motility is completely suppressed
Solution Approach 1:
The method exploits the phase transition between unjammed (motile) and jammed (stationary) states in epithelial cells, where administration of cytokines or inhibitors induces a transition to the jammed phase that halts fibrosis progression while completely suppressing cell motility and migration
4Speed
If EGFR or YAP inhibitors are administered to induce unjammed phase, then cell migration is enhanced, but fibrotic remodeling is promoted
Solution Approach 1:
The method applies the opposite approach to conventional wisdom by using inhibitors of EGFR or YAP to induce the unjammed phase and enhance cell migration, thereby reversing the typical pro-fibrotic effect and promoting epithelial repair rather than fibrotic remodeling
Data Source
AI summary
A method of screening a test compound, e.g., a fibrosis or IPF inhibitor, for induction of an unjammed-to-jammed transition (UJT) in fibrotic primary human bronchial epithelial cells (HBECs) isolated from a subject with a fibrotic lung disease includes culturing the fibrotic primary HBECs at an air-liquid interface for a time sufficient to provide a differentiated pseudostratified epithelium contacting the cultured cells with the test compound; and monitoring the motility of the cultured cells to identify the cultured cells as moving or stationary; wherein stationary cultured cells indicate that the test compound induces the UJT. Also included are methods of identifying lung fibrosis biomarkers.